4:39 PM
Jan 30, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Acute lymphoblastic leukemia (ALL); multiple myeloma (MM)

In vitro and cell culture studies suggest stapled peptide inhibitors of MCL1 could help treat ALL and MM. Modification of previously identified peptide-based inhibitors of MCL1 with hydrocarbon cross-links to stabilize α-helices and...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >